Author response for "Historic real-world outcomes and future benchmarks for patients with diffuse large B-cell lymphoma receiving first- and second-line therapy in Austria – a large single-center experience"Michael Leisch, Thomas Melchardt, Dominik Kiem et al.|Unknown|2025Cited by 0